• Delivered. 2/2017

    Let me welcome you to this issue with some impressive numbers. Since the launch of NAFTA in 1994, U.S. direct investment in Mexico has risen more than sixfold to $92.8 billion in 2015. Over the same period, Mexican exports to the U.S. have surged more than sevenfold to $294.6 billion. The numbers speak for themselves – under NAFTA, Mexico has become a key manufacturing hub for foreign companies supplying the U.S. During these times of political headwinds, will it stay the same in the coming years? We’ll give you an insight in Mexico at the crossroads.

  • Chicago Fashion

    Een video over de DHL fashion week in Chicago, Verenigde Staten.

  • Delivered. 5/2016

    For the automotive industry, segmentation is now the order of the day, as consumer attitudes to cars and driving are increasingly diversified. Our Focus article “Wired for the road ahead” explores this changing landscape in which carmakers have to adapt to the complexity of ever more fractured markets and the rise of technology components in vehicles, and where smart supply chain planning matters more than ever.

  • Zero Emissions 2050

    Wij willen als DHL een betere wereld voor iedereen. Door steeds te innoveren op groenere technologieën hoopt DHL hier aan bij te dragen.

  • Trend report sharing economy logistics

    Logistiek gaat een belangrijke aandeel hebben in het vormgeven van de sharing economy, de deeleconomie. DHL, de wereldwijd logistiek dienstverlener, concludeert in een net uitgebracht trendrapport dat er grote kansen liggen voor de logistiek in het omarmen van digitale platforms en businessmodellen die gericht zijn op het delen van bezit. Het rapport met de titel ‘Sharing Economy Logistics – Rethinking Logistics with access over ownership’ geeft inzicht in de werking van de deeleconomie en presenteert praktische toepassingen voor de logistieke keten.

  • Delivered. 3/2017

    We’re all individuals. While this statement may be an obvious one, when it comes to life sciences and healthcare, it represents a fundamental change in mind set. Where “one drug for all” used to be the prescribed course for an illness, now, with the ever-growing understanding of an individual’s genetics, lifestyle and the characteristics of their condition, the approach to treatments is becoming much more tailored.

Pagina's